WallStreetZenWallStreetZen

NASDAQ: IRMD
Iradimed Corp Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their IRMD stock forecasts and price targets.

Forecast return on equity

Is IRMD forecast to generate an efficient return?

Forecast return on assets

Is IRMD forecast to generate an efficient return on assets?

IRMD revenue forecast

What is IRMD's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$74.1M+13.05%
Avg 2 year Forecast
$79.1M+20.66%
IRMD's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

IRMD revenue growth forecast

How is IRMD forecast to perform vs Medical Devices companies and vs the US market?
Company
13.05%
Industry
10.81%
Market
13.58%
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
IRMD's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

IRMD vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
IRMD$40.36N/AN/A
NNOX$9.07$18.00+98.46%Strong Buy
OFIX$13.02$15.00+15.21%Hold
NVRO$12.32$17.73+43.89%Hold
ZIMV$15.68$16.00+2.04%Sell

Iradimed Stock Forecast FAQ

What is IRMD's revenue growth forecast for 2024-2025?

(NASDAQ: IRMD) Iradimed's forecast annual revenue growth rate of 13.05% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.81%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 13.58%.

Iradimed's revenue in 2024 is $65,562,296.On average, 1 Wall Street analysts forecast IRMD's revenue for 2024 to be $938,567,403, with the lowest IRMD revenue forecast at $938,567,403, and the highest IRMD revenue forecast at $938,567,403.

In 2025, IRMD is forecast to generate $1,001,754,820 in revenue, with the lowest revenue forecast at $1,001,754,820 and the highest revenue forecast at $1,001,754,820.

If you're new to stock investing, here's how to buy Iradimed stock.

What is IRMD's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: IRMD) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.63%.

What is IRMD's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: IRMD) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.